For the BRCA1 and BRCA2 tumor suppressor genes, a 20% wild-type expression of the full-length transcript has been designated as sufficient to prevent tumorigenesis by current VCEP specifications [15]. The gene discussed is BRCA2; the disease is neoplasm.